$Aytu BioPharma (AYTU.US)$ most professional analysts thinks that this is undervalued by more or less 90% compared to its current price, after an in-depth DD about their IGG/IGM point of care test, (which is on the top 4 best point of care test that produces accurate results from 2-15 mins) healight, (which is on the final stages of its testing for an FDA approval) analyzing charts, (the chart seems to be heavily manipulated at the moment) together with a rumor of a possible merger with Carecor (NASDAQ:CERC) I am led to believe that this will be a good swing for those who can park in a position for atleast 2-3 months. It’s up to you how to make your profits based on it’s daily movement but I believe that the parabolic uptrend jump